-
The Birth of the Pharmaceutical Industry
Earlier in the series we talked about how it was the artificial dye industry that gave way to the pharmaceutical industry in the latter half of the 19th century. Let's now examine the first large pharma companies to emerge, and the products they were manufacturing at that time. This will include Farbwerke Höchst, Bayer, and E. Merck, which put themselves on the map by producing drugs like antipyrine, novocaine, aspirin, and even heroin. How did this industry get off the ground? What impact did World War I have on this process? Let's discuss all this and more!
Script by Vittorio Farina
Animation by Cyrene Domogalla: https://cyrenedomogalla.myportfolio.com/
Watch the full series: http://bit.ly/ProfDaveHistoryDrugs
Pharmacology Tutorials: http://bit.ly/ProfDavePharma
Immunology Tutorials: ...
published: 11 Feb 2022
-
The power of the pharmaceutical companies | DW Documentary
How much is a human life worth? An innovative cancer therapy promises to save lives. But it is extremely expensive. Will the insurance companies pay for it? What is the manufacturer's return on investment? And do lobbyists drive up prices?
In 2018, the Kymriah gene therapy was approved in Europe. Immune cells are taken from the patient, genetically reprogrammed into cancer killer cells and returned to the patient as an infusion. The results of the Kymriah study only cover a period of 18 months. In 40 percent of patients, lymph gland cancer does not return during this time. It is not clear whether Kymriah has a long-term effect. The Swiss pharmaceutical company Novartis offers the new therapy - it costs 370,000 Swiss francs per patient. Health insurance companies are not usually prepared t...
published: 28 Oct 2020
-
What is The Pharmaceutical Industry?
What everybody should know about Clinical Trials!
Without clinical trials, we wouldn’t have any vaccines, treatments for cancer, heart disease, diabetes and many others. What should everybody know about Clinical Trials? How are pharmaceuticals and medical devices developed? This is our new video of our series about the basics of clinical trials to give you some answers.
For more insight into our world of Clinical Research, and to be sure not to miss a thing,
Visit us on Instagram: https://www.instagram.com/gcpservice/
Tweet with us on: https://twitter.com/GcpService
LinkedIn: https://www.linkedin.com/company/gcp-service-international-ltd-co-kg
Xing: https://www.xing.com/pages/gcp-serviceinternationalltd-co-kg
Or even visit our Homepage: https://www.gcp-service.com/
It’s all about the ...
published: 13 Jan 2022
-
Big Pharma - How much power do drug companies have? | DW Documentary
The pharmaceutical industry exerts a huge amount of influence on health policy. Some companies develop highly profitable drugs with public money, while others have been found to have covered up serious side effects.
The fight against Covid-19 is further fueling the greed of pharmaceutical companies. Does the industry’s influence threaten public health systems?
The industry has seen major changes in the last decade. Most of the world’s pharmaceuticals are produced by a handful of large corporations, so-called Big Pharma. They’re richer and more powerful than ever. In some cases, they can even call the shots on governmental health policies.
This documentary is the result of more than a year of research, and brings together patients, whistleblowers, lawyers, doctors and politicians, as w...
published: 12 Sep 2021
-
How Drug Prices Work | WSJ
Drug pricing is complicated and secretive. WSJ explains how the flow of money, drugs and rebates behind the scenes may drive up the price of prescription medicine for consumers. Illustration: Mallory Brangan
Don’t miss a WSJ video, subscribe here: http://bit.ly/14Q81Xy
More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Visit the WSJ Video Center: https://wsj.com/video
On Facebook: https://www.facebook.com/pg/wsj/videos/
On Twitter: https://twitter.com/WSJ
On Snapchat: https://on.wsj.com/2ratjSM
#WSJ
published: 30 May 2019
-
Why Pharmaceuticals Are So Complicated In The U.S. | CNBC Marathon
CNBC Marathon explores why pharmaceuticals are so complicated in the United States.
Concerns over prescription drug prices have grown into a big political issue, with nearly one in four Americans saying it's difficult to afford their medications, according to a March 2019 poll by the Kaiser Family Foundation. Pharmacies technically set their own prices for generic drugs, but there are other players involved that complicate the process.
Johnson & Johnson, the biggest pharmaceutical company in the U.S. based on market cap, announced in November 2021 it plans to spin off its consumer business into a new publicly traded company by November 2023. Analysts overwhelmingly say it’s a smart business move, but it could also come with some risks.
Meanwhile, the U.S.'s approval of Biogen's Alzheimer...
published: 03 Jul 2022
-
Treatments for Alzheimer's, other diseases, highlight pharmaceutical industry's historic year
Drug makers rolled out several long-awaited treatments in 2023, including the first-ever drugs shown to slow the effects of Alzheimer's disease and new weight-loss drugs. The year also saw the approval of two new gene therapies to treat sickle cell disease. Dr. Bayo Curry-Winchell, an urgent care physician, joined CBS News to discuss the pharmaceutical industry's 2023.
CBS News Streaming Network is the premier 24/7 anchored streaming news service from CBS News and Stations, available free to everyone with access to the Internet. The CBS News Streaming Network is your destination for breaking news, live events and original reporting locally, nationally and around the globe. Launched in November 2014 as CBSN, the CBS News Streaming Network is available live in 91 countries and on 30 digital...
published: 27 Dec 2023
-
Breakout in ManKind Pharma share #mankindpharma #8bitmarket #sharemarket #breakoutstocks #shorts
mankind pharma share,mankind pharma share price,mankind pharma share news,mankind pharma,mankind pharma share latest news,mankind pharma share price target,mankind pharma share news today,mankind pharma share analysis,mankind pharma share target,mankind pharma shares,mankind pharma stock,8bit market,breakout stocks,breakout stocks for tomorrow,breakout trading,breakout stocks for swing trading,shorts,share market
published: 27 Mar 2024
-
How Big Pharma Gets Dangerous Drugs Approved | System Error
The United States Food and Drug Administration (FDA) has a history of controversy. It’s been blamed for not acting fast enough. It’s also been blamed for rushing products to market.
The FDA has a tough job. It regulates a powerful industry with a lot of money — and questionable practices. With American distrust for Big Pharma at an all-time high, the FDA’s role is more important than ever.
This is how the FDA could be doing a better job at protecting Americans from the greed of some pharmaceutical companies.
Watch more from this series:
Europe’s Agricultural Mafia
https://www.youtube.com/watch?v=3AaGUYzp3J8
The Temple That Sparked an Armed Conflict
https://www.youtube.com/watch?v=NwGP3Q9PDGY&t=2s
The WWF’s Poaching War Is Killing Innocent People
https://www.youtube.com/watch?v=9J6...
published: 20 Oct 2021
-
What is Pharmaceutical Continuous Manufacturing?
Advanced manufacturing technologies like pharmaceutical continuous manufacturing have the potential to allow flexibility and efficiency while reducing the environmental impact of manufacturing many medicines and their ingredients.
Learn more: https://www.usp.org/supply-chain/advanced-manufacturing
published: 06 Dec 2022
11:21
The Birth of the Pharmaceutical Industry
Earlier in the series we talked about how it was the artificial dye industry that gave way to the pharmaceutical industry in the latter half of the 19th century...
Earlier in the series we talked about how it was the artificial dye industry that gave way to the pharmaceutical industry in the latter half of the 19th century. Let's now examine the first large pharma companies to emerge, and the products they were manufacturing at that time. This will include Farbwerke Höchst, Bayer, and E. Merck, which put themselves on the map by producing drugs like antipyrine, novocaine, aspirin, and even heroin. How did this industry get off the ground? What impact did World War I have on this process? Let's discuss all this and more!
Script by Vittorio Farina
Animation by Cyrene Domogalla: https://cyrenedomogalla.myportfolio.com/
Watch the full series: http://bit.ly/ProfDaveHistoryDrugs
Pharmacology Tutorials: http://bit.ly/ProfDavePharma
Immunology Tutorials: http://bit.ly/ProfDaveImmuno
Microbiology/Infectious Diseases Tutorials: http://bit.ly/ProfDaveMicrobio
General Chemistry Tutorials: http://bit.ly/ProfDaveGenChem
Organic Chemistry Tutorials: http://bit.ly/ProfDaveOrgChem
Biochemistry Tutorials: http://bit.ly/ProfDaveBiochem
Biology/Genetics Tutorials: http://bit.ly/ProfDaveBio
Anatomy & Physiology Tutorials: http://bit.ly/ProfDaveAnatPhys
Biopsychology Tutorials: http://bit.ly/ProfDaveBiopsych
EMAIL►
[email protected]
PATREON► http://patreon.com/ProfessorDaveExplains
Check out "Is This Wi-Fi Organic?", my book on disarming pseudoscience!
Amazon: https://amzn.to/2HtNpVH
Bookshop: https://bit.ly/39cKADM
Barnes and Noble: https://bit.ly/3pUjmrn
Book Depository: http://bit.ly/3aOVDlT
https://wn.com/The_Birth_Of_The_Pharmaceutical_Industry
Earlier in the series we talked about how it was the artificial dye industry that gave way to the pharmaceutical industry in the latter half of the 19th century. Let's now examine the first large pharma companies to emerge, and the products they were manufacturing at that time. This will include Farbwerke Höchst, Bayer, and E. Merck, which put themselves on the map by producing drugs like antipyrine, novocaine, aspirin, and even heroin. How did this industry get off the ground? What impact did World War I have on this process? Let's discuss all this and more!
Script by Vittorio Farina
Animation by Cyrene Domogalla: https://cyrenedomogalla.myportfolio.com/
Watch the full series: http://bit.ly/ProfDaveHistoryDrugs
Pharmacology Tutorials: http://bit.ly/ProfDavePharma
Immunology Tutorials: http://bit.ly/ProfDaveImmuno
Microbiology/Infectious Diseases Tutorials: http://bit.ly/ProfDaveMicrobio
General Chemistry Tutorials: http://bit.ly/ProfDaveGenChem
Organic Chemistry Tutorials: http://bit.ly/ProfDaveOrgChem
Biochemistry Tutorials: http://bit.ly/ProfDaveBiochem
Biology/Genetics Tutorials: http://bit.ly/ProfDaveBio
Anatomy & Physiology Tutorials: http://bit.ly/ProfDaveAnatPhys
Biopsychology Tutorials: http://bit.ly/ProfDaveBiopsych
EMAIL►
[email protected]
PATREON► http://patreon.com/ProfessorDaveExplains
Check out "Is This Wi-Fi Organic?", my book on disarming pseudoscience!
Amazon: https://amzn.to/2HtNpVH
Bookshop: https://bit.ly/39cKADM
Barnes and Noble: https://bit.ly/3pUjmrn
Book Depository: http://bit.ly/3aOVDlT
- published: 11 Feb 2022
- views: 199556
42:27
The power of the pharmaceutical companies | DW Documentary
How much is a human life worth? An innovative cancer therapy promises to save lives. But it is extremely expensive. Will the insurance companies pay for it? Wha...
How much is a human life worth? An innovative cancer therapy promises to save lives. But it is extremely expensive. Will the insurance companies pay for it? What is the manufacturer's return on investment? And do lobbyists drive up prices?
In 2018, the Kymriah gene therapy was approved in Europe. Immune cells are taken from the patient, genetically reprogrammed into cancer killer cells and returned to the patient as an infusion. The results of the Kymriah study only cover a period of 18 months. In 40 percent of patients, lymph gland cancer does not return during this time. It is not clear whether Kymriah has a long-term effect. The Swiss pharmaceutical company Novartis offers the new therapy - it costs 370,000 Swiss francs per patient. Health insurance companies are not usually prepared to pay that much and are complaining about a lack of transparency.
But the killer cells were not invented in the Novartis laboratories, but at a US university. When Professor Carl June started his research almost 30 years ago, no pharmaceutical company was interested. It was only thanks to funding from tax money and donations that he was able to develop Kymriah at all. After a story went around the world about a girl with leukemia whose cancer disappeared thanks to Kymriah, the pharmaceutical company contacted Novartis and secured exclusive marketing rights. To launch Kymriah on the market, Novartis funded the necessary clinical trials. It's not an isolated incident: Over 60% of newly approved medicines in the US are developed by small biotech companies or universities. Pharmaceutical companies today frequently act as capital providers, cooperating with universities or buying up biotech companies.
A paradigm shift has taken place in the pharmaceutical industry: Whereas high drug prices used to be justified by research costs, the industry is now using the value of gained lifetime to argue its case.
-------------------------------------------------------------------
DW Documentary gives you knowledge beyond the headlines. Watch high-class documentaries from German broadcasters and international production companies. Meet intriguing people, travel to distant lands, get a look behind the complexities of daily life and build a deeper understanding of current affairs and global events. Subscribe and explore the world around you with DW Documentary.
Subscribe to:
DW Documentary: https://www.youtube.com/channel/UCW39zufHfsuGgpLviKh297Q?sub_confirmation=1#
DW Documental (Spanish): https://www.youtube.com/dwdocumental
DW Documentary وثائقية دي دبليو: (Arabic): https://www.youtube.com/dwdocarabia
For more visit:
http://www.dw.com/en/tv/docfilm/s-3610
Instagram:
https://www.instagram.com/dwdocumentary/
Facebook:
https://www.facebook.com/dw.stories
DW netiquette policy: https://p.dw.com/p/MF1G
https://wn.com/The_Power_Of_The_Pharmaceutical_Companies_|_Dw_Documentary
How much is a human life worth? An innovative cancer therapy promises to save lives. But it is extremely expensive. Will the insurance companies pay for it? What is the manufacturer's return on investment? And do lobbyists drive up prices?
In 2018, the Kymriah gene therapy was approved in Europe. Immune cells are taken from the patient, genetically reprogrammed into cancer killer cells and returned to the patient as an infusion. The results of the Kymriah study only cover a period of 18 months. In 40 percent of patients, lymph gland cancer does not return during this time. It is not clear whether Kymriah has a long-term effect. The Swiss pharmaceutical company Novartis offers the new therapy - it costs 370,000 Swiss francs per patient. Health insurance companies are not usually prepared to pay that much and are complaining about a lack of transparency.
But the killer cells were not invented in the Novartis laboratories, but at a US university. When Professor Carl June started his research almost 30 years ago, no pharmaceutical company was interested. It was only thanks to funding from tax money and donations that he was able to develop Kymriah at all. After a story went around the world about a girl with leukemia whose cancer disappeared thanks to Kymriah, the pharmaceutical company contacted Novartis and secured exclusive marketing rights. To launch Kymriah on the market, Novartis funded the necessary clinical trials. It's not an isolated incident: Over 60% of newly approved medicines in the US are developed by small biotech companies or universities. Pharmaceutical companies today frequently act as capital providers, cooperating with universities or buying up biotech companies.
A paradigm shift has taken place in the pharmaceutical industry: Whereas high drug prices used to be justified by research costs, the industry is now using the value of gained lifetime to argue its case.
-------------------------------------------------------------------
DW Documentary gives you knowledge beyond the headlines. Watch high-class documentaries from German broadcasters and international production companies. Meet intriguing people, travel to distant lands, get a look behind the complexities of daily life and build a deeper understanding of current affairs and global events. Subscribe and explore the world around you with DW Documentary.
Subscribe to:
DW Documentary: https://www.youtube.com/channel/UCW39zufHfsuGgpLviKh297Q?sub_confirmation=1#
DW Documental (Spanish): https://www.youtube.com/dwdocumental
DW Documentary وثائقية دي دبليو: (Arabic): https://www.youtube.com/dwdocarabia
For more visit:
http://www.dw.com/en/tv/docfilm/s-3610
Instagram:
https://www.instagram.com/dwdocumentary/
Facebook:
https://www.facebook.com/dw.stories
DW netiquette policy: https://p.dw.com/p/MF1G
- published: 28 Oct 2020
- views: 747094
3:58
What is The Pharmaceutical Industry?
What everybody should know about Clinical Trials!
Without clinical trials, we wouldn’t have any vaccines, treatments for cancer, heart disease, diabetes and man...
What everybody should know about Clinical Trials!
Without clinical trials, we wouldn’t have any vaccines, treatments for cancer, heart disease, diabetes and many others. What should everybody know about Clinical Trials? How are pharmaceuticals and medical devices developed? This is our new video of our series about the basics of clinical trials to give you some answers.
For more insight into our world of Clinical Research, and to be sure not to miss a thing,
Visit us on Instagram: https://www.instagram.com/gcpservice/
Tweet with us on: https://twitter.com/GcpService
LinkedIn: https://www.linkedin.com/company/gcp-service-international-ltd-co-kg
Xing: https://www.xing.com/pages/gcp-serviceinternationalltd-co-kg
Or even visit our Homepage: https://www.gcp-service.com/
It’s all about the mindset, the GCP-Mindset 💡
https://wn.com/What_Is_The_Pharmaceutical_Industry
What everybody should know about Clinical Trials!
Without clinical trials, we wouldn’t have any vaccines, treatments for cancer, heart disease, diabetes and many others. What should everybody know about Clinical Trials? How are pharmaceuticals and medical devices developed? This is our new video of our series about the basics of clinical trials to give you some answers.
For more insight into our world of Clinical Research, and to be sure not to miss a thing,
Visit us on Instagram: https://www.instagram.com/gcpservice/
Tweet with us on: https://twitter.com/GcpService
LinkedIn: https://www.linkedin.com/company/gcp-service-international-ltd-co-kg
Xing: https://www.xing.com/pages/gcp-serviceinternationalltd-co-kg
Or even visit our Homepage: https://www.gcp-service.com/
It’s all about the mindset, the GCP-Mindset 💡
- published: 13 Jan 2022
- views: 29558
42:27
Big Pharma - How much power do drug companies have? | DW Documentary
The pharmaceutical industry exerts a huge amount of influence on health policy. Some companies develop highly profitable drugs with public money, while others h...
The pharmaceutical industry exerts a huge amount of influence on health policy. Some companies develop highly profitable drugs with public money, while others have been found to have covered up serious side effects.
The fight against Covid-19 is further fueling the greed of pharmaceutical companies. Does the industry’s influence threaten public health systems?
The industry has seen major changes in the last decade. Most of the world’s pharmaceuticals are produced by a handful of large corporations, so-called Big Pharma. They’re richer and more powerful than ever. In some cases, they can even call the shots on governmental health policies.
This documentary is the result of more than a year of research, and brings together patients, whistleblowers, lawyers, doctors and politicians, as well as representatives of the industry. Large laboratories are accused of concealing or downplaying research results to maintain their monopolies. Take the manufacturer Sanofi, whose epilepsy drug Depakine triggered a scandal throughout Europe. In the US, Johnson & Johnson has had to stand trial for driving millions of people into opioid addiction. And Novartis is one of several companies now facing huge fines over improper practices in the treatment of macular degeneration, an eye disease.
The pharmaceutical industry gets support from influential doctors. But only one-fifth of German doctors declare what they receive from drug companies. As the world battles the Coronavirus pandemic, this documentary also looks at the lobbying efforts of manufacturer Gilead, as it seeks approval for a promising drug developed largely with public money. Every company is vying to find the next miracle treatment that will help it succeed against the competition.
#documentary #BigPharma #dwdocumentary
______
DW Documentary gives you knowledge beyond the headlines. Watch top documentaries from German broadcasters and international production companies. Meet intriguing people, travel to distant lands, get a look behind the complexities of daily life and build a deeper understanding of current affairs and global events. Subscribe and explore the world around you with DW Documentary.
Subscribe to:
⮞ DW Documentary (English): https://www.youtube.com/dwdocumentary
⮞ DW Documental (Spanish): https://www.youtube.com/dwdocumental
⮞ DW Documentary (Arabic): https://www.youtube.com/dwdocarabia
⮞ DW Doku (German): https://www.youtube.com/channel/UCH1kA4LQsyjKeW0mPLOAdGQ
⮞ DW Documentary (Hindi): https://www.youtube.com/channel/UC46ccgpPJK-3wLzzQrLGtSg
For more visit: http://www.dw.com/en/tv/docfilm/s-3610
Follow DW Documentary on Instagram: https://www.instagram.com/dwdocumentary/
Follow DW Documental on Facebook: https://www.facebook.com/dwdocumental
We kindly ask viewers to read and stick to the DW netiquette policy on our channel: https://p.dw.com/p/MF1G
https://wn.com/Big_Pharma_How_Much_Power_Do_Drug_Companies_Have_|_Dw_Documentary
The pharmaceutical industry exerts a huge amount of influence on health policy. Some companies develop highly profitable drugs with public money, while others have been found to have covered up serious side effects.
The fight against Covid-19 is further fueling the greed of pharmaceutical companies. Does the industry’s influence threaten public health systems?
The industry has seen major changes in the last decade. Most of the world’s pharmaceuticals are produced by a handful of large corporations, so-called Big Pharma. They’re richer and more powerful than ever. In some cases, they can even call the shots on governmental health policies.
This documentary is the result of more than a year of research, and brings together patients, whistleblowers, lawyers, doctors and politicians, as well as representatives of the industry. Large laboratories are accused of concealing or downplaying research results to maintain their monopolies. Take the manufacturer Sanofi, whose epilepsy drug Depakine triggered a scandal throughout Europe. In the US, Johnson & Johnson has had to stand trial for driving millions of people into opioid addiction. And Novartis is one of several companies now facing huge fines over improper practices in the treatment of macular degeneration, an eye disease.
The pharmaceutical industry gets support from influential doctors. But only one-fifth of German doctors declare what they receive from drug companies. As the world battles the Coronavirus pandemic, this documentary also looks at the lobbying efforts of manufacturer Gilead, as it seeks approval for a promising drug developed largely with public money. Every company is vying to find the next miracle treatment that will help it succeed against the competition.
#documentary #BigPharma #dwdocumentary
______
DW Documentary gives you knowledge beyond the headlines. Watch top documentaries from German broadcasters and international production companies. Meet intriguing people, travel to distant lands, get a look behind the complexities of daily life and build a deeper understanding of current affairs and global events. Subscribe and explore the world around you with DW Documentary.
Subscribe to:
⮞ DW Documentary (English): https://www.youtube.com/dwdocumentary
⮞ DW Documental (Spanish): https://www.youtube.com/dwdocumental
⮞ DW Documentary (Arabic): https://www.youtube.com/dwdocarabia
⮞ DW Doku (German): https://www.youtube.com/channel/UCH1kA4LQsyjKeW0mPLOAdGQ
⮞ DW Documentary (Hindi): https://www.youtube.com/channel/UC46ccgpPJK-3wLzzQrLGtSg
For more visit: http://www.dw.com/en/tv/docfilm/s-3610
Follow DW Documentary on Instagram: https://www.instagram.com/dwdocumentary/
Follow DW Documental on Facebook: https://www.facebook.com/dwdocumental
We kindly ask viewers to read and stick to the DW netiquette policy on our channel: https://p.dw.com/p/MF1G
- published: 12 Sep 2021
- views: 3139259
6:45
How Drug Prices Work | WSJ
Drug pricing is complicated and secretive. WSJ explains how the flow of money, drugs and rebates behind the scenes may drive up the price of prescription medici...
Drug pricing is complicated and secretive. WSJ explains how the flow of money, drugs and rebates behind the scenes may drive up the price of prescription medicine for consumers. Illustration: Mallory Brangan
Don’t miss a WSJ video, subscribe here: http://bit.ly/14Q81Xy
More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Visit the WSJ Video Center: https://wsj.com/video
On Facebook: https://www.facebook.com/pg/wsj/videos/
On Twitter: https://twitter.com/WSJ
On Snapchat: https://on.wsj.com/2ratjSM
#WSJ
https://wn.com/How_Drug_Prices_Work_|_Wsj
Drug pricing is complicated and secretive. WSJ explains how the flow of money, drugs and rebates behind the scenes may drive up the price of prescription medicine for consumers. Illustration: Mallory Brangan
Don’t miss a WSJ video, subscribe here: http://bit.ly/14Q81Xy
More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Visit the WSJ Video Center: https://wsj.com/video
On Facebook: https://www.facebook.com/pg/wsj/videos/
On Twitter: https://twitter.com/WSJ
On Snapchat: https://on.wsj.com/2ratjSM
#WSJ
- published: 30 May 2019
- views: 276948
1:01:48
Why Pharmaceuticals Are So Complicated In The U.S. | CNBC Marathon
CNBC Marathon explores why pharmaceuticals are so complicated in the United States.
Concerns over prescription drug prices have grown into a big political issue...
CNBC Marathon explores why pharmaceuticals are so complicated in the United States.
Concerns over prescription drug prices have grown into a big political issue, with nearly one in four Americans saying it's difficult to afford their medications, according to a March 2019 poll by the Kaiser Family Foundation. Pharmacies technically set their own prices for generic drugs, but there are other players involved that complicate the process.
Johnson & Johnson, the biggest pharmaceutical company in the U.S. based on market cap, announced in November 2021 it plans to spin off its consumer business into a new publicly traded company by November 2023. Analysts overwhelmingly say it’s a smart business move, but it could also come with some risks.
Meanwhile, the U.S.'s approval of Biogen's Alzheimer's drug Aduhelm was heralded as a historic triumph in the fight against the memory-robbing disease. But so far, Biogen has reported only a fraction of Aduhelm revenue to meet Wall Street's expectations. Patients and physicians have been torn over the drug's murky clinical data and its high price tag. Aduhelm's lackluster launch has been costly, forcing Biogen to take measures to keep the drug afloat.
For Covid-19 vaccine maker, BioNTech, they had little recognition outside of their hometown of Germany prior to the pandemic. Over a month and a half before the World Health Organization officially declared a pandemic, BioNTech CEO Uğur Şahin met with his wife, BioNTech’s co-founder and chief medical officer Özlem Türeci, and together they agreed to redirect most of the company’s resources to developing a vaccine. The founders were confident in the potential of their mRNA technology, which they knew could trigger a powerful immune response. That confidence wasn’t necessarily shared by the broader medical community. No mRNA vaccine or treatment had ever been approved before. But the couple’s timely breakthrough was actually decades in the making.
CNBC Marathon brings together the best of CNBC on YouTube.
Chapters:
00:00 Introduction
00:31 Why U.S. pharmacies overcharge (Published August 2021)
16:35 The rise of BioNTech (Published October 2021)
34:21 Why the biggest pharma company in the U.S. is breaking up (Published January 2022)
45:42 What’s the controversy behind Biogen’s Alzheimer’s drug? (Published January 2022)
» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: http://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC
Follow CNBC News on Google+: http://cnb.cx/PlusCNBC
Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC
#cnbc
Why Pharmaceuticals Are So Complicated In The U.S. | CNBC Marathon
https://wn.com/Why_Pharmaceuticals_Are_So_Complicated_In_The_U.S._|_Cnbc_Marathon
CNBC Marathon explores why pharmaceuticals are so complicated in the United States.
Concerns over prescription drug prices have grown into a big political issue, with nearly one in four Americans saying it's difficult to afford their medications, according to a March 2019 poll by the Kaiser Family Foundation. Pharmacies technically set their own prices for generic drugs, but there are other players involved that complicate the process.
Johnson & Johnson, the biggest pharmaceutical company in the U.S. based on market cap, announced in November 2021 it plans to spin off its consumer business into a new publicly traded company by November 2023. Analysts overwhelmingly say it’s a smart business move, but it could also come with some risks.
Meanwhile, the U.S.'s approval of Biogen's Alzheimer's drug Aduhelm was heralded as a historic triumph in the fight against the memory-robbing disease. But so far, Biogen has reported only a fraction of Aduhelm revenue to meet Wall Street's expectations. Patients and physicians have been torn over the drug's murky clinical data and its high price tag. Aduhelm's lackluster launch has been costly, forcing Biogen to take measures to keep the drug afloat.
For Covid-19 vaccine maker, BioNTech, they had little recognition outside of their hometown of Germany prior to the pandemic. Over a month and a half before the World Health Organization officially declared a pandemic, BioNTech CEO Uğur Şahin met with his wife, BioNTech’s co-founder and chief medical officer Özlem Türeci, and together they agreed to redirect most of the company’s resources to developing a vaccine. The founders were confident in the potential of their mRNA technology, which they knew could trigger a powerful immune response. That confidence wasn’t necessarily shared by the broader medical community. No mRNA vaccine or treatment had ever been approved before. But the couple’s timely breakthrough was actually decades in the making.
CNBC Marathon brings together the best of CNBC on YouTube.
Chapters:
00:00 Introduction
00:31 Why U.S. pharmacies overcharge (Published August 2021)
16:35 The rise of BioNTech (Published October 2021)
34:21 Why the biggest pharma company in the U.S. is breaking up (Published January 2022)
45:42 What’s the controversy behind Biogen’s Alzheimer’s drug? (Published January 2022)
» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: http://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC
Follow CNBC News on Google+: http://cnb.cx/PlusCNBC
Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC
#cnbc
Why Pharmaceuticals Are So Complicated In The U.S. | CNBC Marathon
- published: 03 Jul 2022
- views: 1141029
3:22
Treatments for Alzheimer's, other diseases, highlight pharmaceutical industry's historic year
Drug makers rolled out several long-awaited treatments in 2023, including the first-ever drugs shown to slow the effects of Alzheimer's disease and new weight-l...
Drug makers rolled out several long-awaited treatments in 2023, including the first-ever drugs shown to slow the effects of Alzheimer's disease and new weight-loss drugs. The year also saw the approval of two new gene therapies to treat sickle cell disease. Dr. Bayo Curry-Winchell, an urgent care physician, joined CBS News to discuss the pharmaceutical industry's 2023.
CBS News Streaming Network is the premier 24/7 anchored streaming news service from CBS News and Stations, available free to everyone with access to the Internet. The CBS News Streaming Network is your destination for breaking news, live events and original reporting locally, nationally and around the globe. Launched in November 2014 as CBSN, the CBS News Streaming Network is available live in 91 countries and on 30 digital platforms and apps, as well as on CBSNews.com and Paramount+.
Subscribe to the CBS News YouTube channel: https://youtube.com/cbsnews
Watch CBS News: https://cbsn.ws/1PlLpZ7c
Download the CBS News app: https://cbsn.ws/1Xb1WC8
Follow CBS News on Instagram: https://www.instagram.com/cbsnews/
Like CBS News on Facebook: https://facebook.com/cbsnews
Follow CBS News on Twitter: https://twitter.com/cbsnews
Subscribe to our newsletters: https://cbsn.ws/1RqHw7T
Try Paramount+ free: https://bit.ly/2OiW1kZ
For video licensing inquiries, contact:
[email protected]
https://wn.com/Treatments_For_Alzheimer's,_Other_Diseases,_Highlight_Pharmaceutical_Industry's_Historic_Year
Drug makers rolled out several long-awaited treatments in 2023, including the first-ever drugs shown to slow the effects of Alzheimer's disease and new weight-loss drugs. The year also saw the approval of two new gene therapies to treat sickle cell disease. Dr. Bayo Curry-Winchell, an urgent care physician, joined CBS News to discuss the pharmaceutical industry's 2023.
CBS News Streaming Network is the premier 24/7 anchored streaming news service from CBS News and Stations, available free to everyone with access to the Internet. The CBS News Streaming Network is your destination for breaking news, live events and original reporting locally, nationally and around the globe. Launched in November 2014 as CBSN, the CBS News Streaming Network is available live in 91 countries and on 30 digital platforms and apps, as well as on CBSNews.com and Paramount+.
Subscribe to the CBS News YouTube channel: https://youtube.com/cbsnews
Watch CBS News: https://cbsn.ws/1PlLpZ7c
Download the CBS News app: https://cbsn.ws/1Xb1WC8
Follow CBS News on Instagram: https://www.instagram.com/cbsnews/
Like CBS News on Facebook: https://facebook.com/cbsnews
Follow CBS News on Twitter: https://twitter.com/cbsnews
Subscribe to our newsletters: https://cbsn.ws/1RqHw7T
Try Paramount+ free: https://bit.ly/2OiW1kZ
For video licensing inquiries, contact:
[email protected]
- published: 27 Dec 2023
- views: 2173
0:45
Breakout in ManKind Pharma share #mankindpharma #8bitmarket #sharemarket #breakoutstocks #shorts
mankind pharma share,mankind pharma share price,mankind pharma share news,mankind pharma,mankind pharma share latest news,mankind pharma share price target,mank...
mankind pharma share,mankind pharma share price,mankind pharma share news,mankind pharma,mankind pharma share latest news,mankind pharma share price target,mankind pharma share news today,mankind pharma share analysis,mankind pharma share target,mankind pharma shares,mankind pharma stock,8bit market,breakout stocks,breakout stocks for tomorrow,breakout trading,breakout stocks for swing trading,shorts,share market
https://wn.com/Breakout_In_Mankind_Pharma_Share_Mankindpharma_8Bitmarket_Sharemarket_Breakoutstocks_Shorts
mankind pharma share,mankind pharma share price,mankind pharma share news,mankind pharma,mankind pharma share latest news,mankind pharma share price target,mankind pharma share news today,mankind pharma share analysis,mankind pharma share target,mankind pharma shares,mankind pharma stock,8bit market,breakout stocks,breakout stocks for tomorrow,breakout trading,breakout stocks for swing trading,shorts,share market
- published: 27 Mar 2024
- views: 32
13:33
How Big Pharma Gets Dangerous Drugs Approved | System Error
The United States Food and Drug Administration (FDA) has a history of controversy. It’s been blamed for not acting fast enough. It’s also been blamed for rushin...
The United States Food and Drug Administration (FDA) has a history of controversy. It’s been blamed for not acting fast enough. It’s also been blamed for rushing products to market.
The FDA has a tough job. It regulates a powerful industry with a lot of money — and questionable practices. With American distrust for Big Pharma at an all-time high, the FDA’s role is more important than ever.
This is how the FDA could be doing a better job at protecting Americans from the greed of some pharmaceutical companies.
Watch more from this series:
Europe’s Agricultural Mafia
https://www.youtube.com/watch?v=3AaGUYzp3J8
The Temple That Sparked an Armed Conflict
https://www.youtube.com/watch?v=NwGP3Q9PDGY&t=2s
The WWF’s Poaching War Is Killing Innocent People
https://www.youtube.com/watch?v=9J6iJg6NUOA&t=228s
Subscribe to VICE News here: http://bit.ly/Subscribe-to-VICE-News
Check out VICE News for more: http://vicenews.com
Follow VICE News here:
Facebook: https://www.facebook.com/vicenews
Twitter: https://twitter.com/vicenews
Tumblr: http://vicenews.tumblr.com/
Instagram: http://instagram.com/vicenews
More videos from the VICE network: https://www.fb.com/vicevideo
#VICENews #News
https://wn.com/How_Big_Pharma_Gets_Dangerous_Drugs_Approved_|_System_Error
The United States Food and Drug Administration (FDA) has a history of controversy. It’s been blamed for not acting fast enough. It’s also been blamed for rushing products to market.
The FDA has a tough job. It regulates a powerful industry with a lot of money — and questionable practices. With American distrust for Big Pharma at an all-time high, the FDA’s role is more important than ever.
This is how the FDA could be doing a better job at protecting Americans from the greed of some pharmaceutical companies.
Watch more from this series:
Europe’s Agricultural Mafia
https://www.youtube.com/watch?v=3AaGUYzp3J8
The Temple That Sparked an Armed Conflict
https://www.youtube.com/watch?v=NwGP3Q9PDGY&t=2s
The WWF’s Poaching War Is Killing Innocent People
https://www.youtube.com/watch?v=9J6iJg6NUOA&t=228s
Subscribe to VICE News here: http://bit.ly/Subscribe-to-VICE-News
Check out VICE News for more: http://vicenews.com
Follow VICE News here:
Facebook: https://www.facebook.com/vicenews
Twitter: https://twitter.com/vicenews
Tumblr: http://vicenews.tumblr.com/
Instagram: http://instagram.com/vicenews
More videos from the VICE network: https://www.fb.com/vicevideo
#VICENews #News
- published: 20 Oct 2021
- views: 369664
2:37
What is Pharmaceutical Continuous Manufacturing?
Advanced manufacturing technologies like pharmaceutical continuous manufacturing have the potential to allow flexibility and efficiency while reducing the envir...
Advanced manufacturing technologies like pharmaceutical continuous manufacturing have the potential to allow flexibility and efficiency while reducing the environmental impact of manufacturing many medicines and their ingredients.
Learn more: https://www.usp.org/supply-chain/advanced-manufacturing
https://wn.com/What_Is_Pharmaceutical_Continuous_Manufacturing
Advanced manufacturing technologies like pharmaceutical continuous manufacturing have the potential to allow flexibility and efficiency while reducing the environmental impact of manufacturing many medicines and their ingredients.
Learn more: https://www.usp.org/supply-chain/advanced-manufacturing
- published: 06 Dec 2022
- views: 27382